The report is designed to be a comprehensive business tool to provide an in-depth look at the market for immunoassays. The geographic scope of the report is global. The report reviews each type of immunoassay and reviews technologies associated with immunoassays and equipment. The report also explores market size, identifies market participants and investigates patents in the immunoassays market.
The global market for immunoassays is divided into categories by immunoassay type and by application as follows.
By product
- Enzyme immunoassays.
- Fluorescent immunoassays.
- Radioimmunoassays.
- Chemiluminescent immunoassays.
- Lateral flow immunoassays and multiplex immunoassays.
By application
- Diabetes.
- Drug screening.
- Infectious diseases.
- Cancer.
- Cardiology.
- Reproductive.
- Other immunoassays.
Each area is covered in detail, identifying current products in the market in the base year 2021, measuring current market size and identifying current and potential market drivers, forecasting for 2027, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2021.
Report Includes
- 124 data tables and 4 additional tables
- An up-to-date review and analysis of the global markets for immunoassays and related technologies
- Analyses of the global market trends, with historic sales data for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Estimation of the actual market size and revenue forecast for global immunoassays market in USD millions, and corresponding market share analysis based on product type, application, and region
- Discussion of the major market dynamics, key shifts and regulations, industry specific challenges, and other region-specific macroeconomic factors affecting the market for immunoassays as a basis for projecting demand over the next few years (2022-2027)
- Insight into prevalence of infectious disease, metabolic disorders and chronic ailments; along with the recent breakthrough innovations, clinical trials, and value chain analyses
- Assessment of the recent industry structure for microbiome therapeutics, ongoing research (R&D) activities, analysis of the competitive environment, and COVID-19 impact on the biotech industry
- Review of the patents and patent applications on immunoassays testing and applications
- Competitive landscape of this market featuring leading biopharmaceutical companies, their product portfolios, financial performances, and market share analysis based on recent segmental revenues
- Company profiles of major players within the industry, including Abbott Laboratories, Biomerieux S.A., F. Hoffmann-La Roche Ltd., Siemens Healthineers, and Thermo Fisher Scientific
Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing This Study
1.3 What's New in This Update?
1.4 Scope of Report
1.5 Methodology
1.6 Information Sources
1.6.1 Primary Research
1.6.2 Secondary Research
1.7 Geographic Breakdown
1.8 Analyst's Credentials
1.9 Custom Research
1.10 Related Research Reports
Chapter 2 Summary and Highlights
2.1 Introduction
Chapter 3 Market Overview
3.1 Definitions and Overview
3.1.1 Classifying immunoassays
3.2 Types of Immunoassays
3.2.1 Enzyme immunoassay (EIA)
3.2.2 Radioimmunoassay (RIA)
3.2.3 Fluorescent Immunoassay (FIA)
3.2.4 Chemiluminescent Immunoassay (CLIA)
3.2.5 Lateral Flow Immunoassays (LFIA)
3.2.6 Multiplex Immunoassay (MIA)
3.3 Applications of Immunoassays
3.3.1 Clinical Diagnostics and Drug Monitoring
3.3.2 Biopharmaceutical Analysis
3.3.3 Food Testing
3.3.4 Environmental Monitoring
3.3.5 Diagnostic Tests
Chapter 4 Market Dynamics
4.1 Market Dynamics
4.1.1 Drivers
4.1.2 Trends
4.1.3 Opportunities
4.1.4 Restraints
Chapter 5 Impact of the COVID-19 Pandemic
5.1 Introduction
5.2 Impact of COVID-19 Pandemic on the Medical Device and Pharma Industries
5.3 Impact of the COVID-19 Pandemic on the Medical Device and Pharmaceutical Product Segments
5.4 Impact of the COVID-19 Pandemic on the Market for Immunoassay Tests
Chapter 6 Global Market for Immunoassays
6.1 World Demand for Immunoassays
Chapter 7 Market Breakdown by Type of Test
7.1 Introduction
7.2 Enzyme Immunoassay (ELISA)
7.2.1 North America
7.2.2 Europe
7.2.3 Asia-Pacific
7.2.4 RoW
7.3 Chemiluminescent Immunoassay (CLIA)
7.3.1 North America
7.3.2 Europe
7.3.3 Asia-Pacific
7.3.4 RoW
7.4 Fluorescent Immunoassay (FIA)
7.4.1 North America
7.4.2 Europe
7.4.3 Asia-Pacific
7.4.4 RoW
7.5 Radioimmunoassay (RIA)
7.5.1 North America
7.5.2 Europe
7.5.3 Asia-Pacific
7.5.4 RoW
7.6 Lateral Flow Immunoassay (LFIA)/Multiplex Immunoassay (MIA)
7.6.1 North America
7.6.2 Europe
7.6.3 Asia-Pacific
7.6.4 RoW
Chapter 8 Market Breakdown by Application
8.1 Introduction
8.2 Diabetes
8.2.1 North America
8.2.2 Europe
8.2.3 Asia-Pacific
8.2.4 RoW
8.3 Drug Screening
8.3.1 North America
8.3.2 Europe
8.3.3 Asia-Pacific
8.3.4 RoW
8.4 Infectious Diseases
8.4.1 North America
8.4.2 Europe
8.4.3 Asia-Pacific
8.4.4 RoW
8.5 Cancer
8.5.1 North America
8.5.2 Europe
8.5.3 Asia-Pacific
8.5.4 RoW
8.6 Cardiology
8.6.1 North America
8.6.2 Europe
8.6.3 Asia-Pacific
8.6.4 RoW
8.7 Reproductive Medicine
8.7.1 North America
8.7.2 Europe
8.7.3 Asia-Pacific
8.7.4 RoW
8.8 Other Applications of Immunoassay Tests
8.8.1 North America
8.8.2 Europe
8.8.3 Asia-Pacific
8.8.4 RoW
Chapter 9 Competitive Landscape
9.1 Industry Scenario
9.2 Company Market Shares
9.3 Competitive Landscape by Type of Test
9.4 Competitive Landscape by Application
Chapter 10 Patents
10.1 Patent Analysis by Manufacturer
Chapter 11 Company Profiles
- Abbott Laboratories
- Abcam Plc
- Beckman Coulter (Danaher Corp.)
- Biomerieux S.A.
- Bio-Rad Laboratories Inc.
- Diasorin
- Merck Inc.
- Mindray
- Orasure Technologies
- Perkin Elmer
- Quidel Corp.
- Randox Laboratories Ltd.
- Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
- Sd Biosensor
- Siemens Healthineers
- Thermo Fisher Scientific Inc.
Chapter 12 Appendix: Acronyms
List of Tables
Summary Table: Global Market for Immunoassay Tests, by Type of Test, Through 2027
Table 1: Global Burden of Disease, by Cause, 2019
Table 2: Global Population, Aged 60 and Older, 2010-2050
Table 3: Global Market for Immunoassay Tests, Through 2027
Table 4: Global Market for Immunoassay Tests, by Region, Through 2027
Table 5: North American Market for Immunoassay Tests, Through 2027
Table 6: North American Market for Immunoassay Tests, by Country, Through 2027
Table 7: European Market for Immunoassay Tests, Through 2027
Table 8: European Market for Immunoassay Tests, by Country, Through 2027
Table 9: Asia-Pacific Market for Immunoassay Tests, Through 2027
Table 10: Asia-Pacific Market for Immunoassay Tests, by Country, Through 2027
Table 11: RoW Market for Immunoassay Tests, Through 2027
Table 12: Global Market for Immunoassay Tests, by Type of Test, Through 2027
Table 13: Global Market for ELISA Tests, Through 2027
Table 14: Global Market for ELISA Tests, by Region, Through 2027
Table 15: North American Market for ELISA Tests, Through 2027
Table 16: North American Market for ELISA Tests, by Country, Through 2027
Table 17: European Market for ELISA Tests, Through 2027
Table 18: European Market for ELISA Tests, by Country, Through 2027
Table 19: Asia-Pacific Market for ELISA Tests, Through 2027
Table 20: Asia-Pacific Market for ELISA Tests, by Country, Through 2027
Table 21: RoW Market for ELISA Tests, Through 2027
Table 22: Global Market for CLIA Tests, Through 2027
Table 23: Global Market for CLIA Tests, by Region, Through 2027
Table 24: North American Market for CLIA Tests, Through 2027
Table 25: North American Market for CLIA Tests, by Country, Through 2027
Table 26: European Market for CLIA Tests, Through 2027
Table 27: European Market for CLIA Tests, by Country, Through 2027
Table 28: Asia-Pacific Market for CLIA Tests, Through 2027
Table 29: Asia-Pacific Market for CLIA Tests, by Country, Through 2027
Table 30: RoW Market for CLIA Tests, Through 2027
Table 31: Global Market for FIA Tests, Through 2027
Table 32: Global Market for FIA Tests, by Region, Through 2027
Table 33: North American Market for FIA Tests, Through 2027
Table 34: North American Market for FIA Tests, by Country, Through 2027
Table 35: European Market for FIA Tests, Through 2027
Table 36: European Market for FIA Tests, by Country, Through 2027
Table 37: Asia-Pacific Market for FIA Tests, Through 2027
Table 38: Asia-Pacific Market for FIA Tests, by Country, Through 2027
Table 39: RoW Market for FIA Tests, Through 2027
Table 40: Global Market for RIA Tests, Through 2027
Table 41: Global Market for RIA Tests, by Region, Through 2027
Table 42: North American Market for RIA Tests, Through 2027
Table 43: North American Market for RIA Tests, by Country, Through 2027
Table 44: European Market for RIA Tests, Through 2027
Table 45: European Market for RIA Tests, by Country, Through 2027
Table 46: Asia-Pacific Market for RIA Tests, Through 2027
Table 47: Asia-Pacific Market for RIA Tests, by Country, Through 2027
Table 48: RoW Market for RIA Tests, Through 2027
Table 49: Global Market for LFIA and MIA Tests, Through 2027
Table 50: Global Market for LFIA and MIA Tests, by Region, Through 2027
Table 51: North American Market for LFIA and MIA Tests, Through 2027
Table 52: North American Market for LFIA and MIA Tests, by Country, Through 2027
Table 53: European Market for LFIA and MIA Tests, Through 2027
Table 54: European Market for LFIA and MIA Tests, by Country, Through 2027
Table 55: Asia-Pacific Market for LFIA and MIA Tests, Through-2027
Table 56: Asia-Pacific Market for LFIA and MIA Tests, by Country, Through 2027
Table 57: RoW Market for LFIA and MIA Tests, Through 2027
Table 58: Global Market for Immunoassay Tests, by Application, Through 2027
Table 59: Global Market for Immunoassay Tests for the Detection of Diabetes, Through 2027
Table 60: Global Market for Immunoassay Tests for the Detection of Diabetes, by Region, Through 2027
Table 61: North American Market for Immunoassay Tests for the Detection of Diabetes, Through 2027
Table 62: North American Market for Immunoassay Tests for the Detection of Diabetes, by Country, Through 2027
Table 63: European Market for Immunoassay Tests for the Detection of Diabetes, Through 2027
Table 64: European Market for Immunoassay Tests for the Detection of Diabetes, by Country, Through 2027
Table 65: Asia-Pacific Market for Immunoassay Tests for the Detection of Diabetes, Through 2027
Table 66: Asia-Pacific Market for Immunoassay Tests for the Detection of Diabetes, by Country, Through 2027
Table 67: RoW Market for Immunoassay Tests for the Detection of Diabetes, Through 2027
Table 68: Global Market for Immunoassay Tests for Drug Screening, Through 2027
Table 69: Global Market for Immunoassay Tests for Drug Screening, by Region, Through 2027
Table 70: North American Market for Immunoassay Tests for Drug Screening, Through 2027
Table 71: North American Market for Immunoassay Tests for Drug Screening, by Country, Through 2027
Table 72: European Market for Immunoassay Tests for Drug Screening, Through 2027
Table 73: European Market for Immunoassay Tests for Drug Screening, by Country, Through 2027
Table 74: Asia-Pacific Market for Immunoassay Tests for Drug Screening, Through 2027
Table 75: Asia-Pacific Market for Immunoassay Tests for Drug Screening, by Country, Through 2027
Table 76: RoW Market for Immunoassay Tests for Drug Screening, Through 2027
Table 77: Global Market for Immunoassay Tests for the Detection of Infectious Diseases, Through 2027
Table 78: Global Market for Immunoassay Tests for the Detection of Infectious Diseases, by Region, Through 2027
Table 79: North American Market for Immunoassay Tests for the Detection of Infectious Diseases, Through 2027
Table 80: North American Market for Immunoassay Tests for the Detection of Infectious Diseases, by Country, Through 2027
Table 81: European Market for Immunoassay Tests for the Detection of Infectious Diseases, Through 2027
Table 82: European Market for Immunoassay Tests for the Detection of Infectious Diseases, by Country, Through 2027
Table 83: Asia-Pacific Market for Immunoassay Tests for the Detection of Infectious Diseases, Through 2027
Table 84: Asia-Pacific Market for Immunoassay Tests for the Detection of Infectious Diseases, by Country, Through 2027
Table 85: RoW Market for Immunoassay Tests for the Detection of Infectious Diseases, Through 2027
Table 86: Global Market for Immunoassay Tests for the Detection of Cancer, Through 2027
Table 87: Global Market for Immunoassay Tests for the Detection of Cancer, by Region, Through 2027
Table 88: North American Market for Immunoassay Tests for the Detection of Cancer, Through 2027
Table 89: North American Market for Immunoassay Tests for the Detection of Cancer, by Country, Through 2027
Table 90: European Market for Immunoassay Tests for the Detection of Cancer, Through 2027
Table 91: European Market for Immunoassay Tests for the Detection of Cancer, by Country, Through 2027
Table 92: Asia-Pacific Market for Immunoassay Tests for the Detection of Cancer, Through 2027
Table 93: Asia-Pacific Market for Immunoassay Tests for the Detection of Cancer, by Country, Through 2027
Table 94: RoW Market for Immunoassay Tests for the Detection of Cancer, Through 2027
Table 95: Global Market for Immunoassay Tests for the Detection of Cardiovascular Disease, Through 2027
Table 96: Global Market for Immunoassay Tests for the Detection of Cardiovascular Disease, by Region, Through 2027
Table 97: North American Market for Immunoassay Tests for the Detection of Cardiovascular Disease, Through 2027
Table 98: North American Market for Immunoassay Tests for the Detection of Cardiovascular Disease, by Country, Through 2027
Table 99: European Market for Immunoassay Tests for the Detection of Cardiovascular Disease, Through 2027
Table 100: European Market for Immunoassay Tests for the Detection of Cardiovascular Disease, by Country, Through 2027
Table 101: Asia-Pacific Market for Immunoassay Tests for the Detection of Cardiovascular Disease, Through 2027
Table 102: Asia-Pacific Market for Immunoassay Tests for the Detection of Cardiovascular Disease, by Country, Through 2027
Table 103: RoW Market for Immunoassay Tests for the Detection of Cardiovascular Disease, Through 2027
Table 104: Global Market for Immunoassay Tests in Reproductive Medicine, Through 2027
Table 105: Global Market for Immunoassay Tests in Reproductive Medicine, by Region, Through 2027
Table 106: North American Market for Immunoassay Tests in Reproductive Medicine, Through 2027
Table 107: North American Market for Immunoassay Tests in Reproductive Medicine, by Country, Through 2027
Table 108: European Market for Immunoassay Tests in Reproductive Medicine, Through 2027
Table 109: European Market for Immunoassay Tests in Reproductive Medicine, by Country, Through 2027
Table 110: Asia-Pacific Market for Immunoassay Tests in Reproductive Medicine, Through 2027
Table 111: Asia-Pacific Market for Immunoassay Tests in Reproductive Medicine, by Country, Through 2027
Table 112: RoW Market for Immunoassay Tests in Reproductive Medicine, Through 2027
Table 113: Global Market for Other Applications of Immunoassay Tests, Through 2027
Table 114: Global Market for Other Applications of Immunoassay Tests, by Region, Through 2027
Table 115: North American Market for Other Applications of Immunoassay Tests, Through 2027
Table 116: North American Market for Other Applications of Immunoassay Tests, by Country, Through 2027
Table 117: European Market for Other Applications of Immunoassay Tests, Through 2027
Table 118: European Market for Other Applications of Immunoassay Tests, by Country, Through 2027
Table 119: Asia-Pacific Market for Other Applications of Immunoassay Tests, Through 2027
Table 120: Asia-Pacific Market for Other Applications of Immunoassay Tests, by Country, Through 2027
Table 121: RoW Market for Other Applications of Immunoassay Tests, Through 2027
Table 122: Patents on Immunoassays and Related Technology, 2015-Present
Table 123: Selected Patents on Immunoassays and Related Technology, by Company, 2015-Present
Table 124: Selected Active Patents on Immunoassays and Related Technology, by Company, 2015-Present
Table 125: F. Hoffmann-La Roche Ltd.: Financials, 2019-2021
Table 126: F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2019-2021
Table 127: Acronyms Used in This Report
List of Figures
Summary Figure A: Global Market for Immunoassay Tests, by Type of Test, 2019-2027
Summary Figure B: Global Market Shares of Immunoassays, by Type of Test, 2021
Figure 1: Global Company Market Shares of Immunoassay Tests, 2021
Figure 2: Global Company Market Shares of ELISA Tests, 2021
Figure 3: Global Company Market Shares of CLIA Tests, 2021
Figure 4: Global Company Market Shares of FIA Tests, 2021
Figure 5: Global Company Market Shares of RIA Tests, 2021
Figure 6: Global Company Market Shares of LFIA and MIA Tests, 2021
Figure 7: Global Market for Company Market Shares of Immunoassay Tests for the Detection of Diabetes, 2021
Figure 8: Global Company Market Shares of Immunoassay Tests for Drug Screening, 2021
Figure 9: Global Company Market Shares of Immunoassay Tests for the Detection of Infectious Diseases, 2021
Figure 10: Global Company Market Shares of Immunoassay Tests for the Detection of Cancer, 2021
Figure 11: Global Company Market Shares of Immunoassay Tests for the Detection of Cardiovascular Disease, 2021
Figure 12: Global Company Market Shares of Immunoassay Tests in Reproductive Medicine, 2021
Figure 13: Global Company Market Shares of Other Applications of Immunoassay Tests, 2021
Figure 14: Abbott: Annual Revenue, 2018-2021
Figure 15: Abbott: Revenue Share, by Business Segment, 2021
Figure 16: Biomerieux: Annual Revenue, 2019-2021
Figure 17: Biomerieux: Revenue Share, by Business Segment, 2021
Figure 18: Biomerieux: Sales Share, by Region, 2021
Figure 19: Bio-Rad Laboratories Inc.: Annual Revenue, 2019-2021
Figure 20: Bio-Rad Laboratories Inc.: Revenue Share, by Business Segment, 2021
Figure 21: Bio-Rad Laboratories Inc.: Sales Share, by Region, 2021
Figure 22: DiaSorin: Annual Revenue, 2019-2021
Figure 23: DiaSorin: Immunoassays Revenue, 2019-2021
Figure 24: Quidel Corp: Annual Revenue, 2019-2021
Figure 25: Quidel Corp: Immunoassays Revenue, 2019-2021
Figure 26: Siemens Healthineers: Annual Revenue, 2019-2021
Figure 27: Siemens Healthineers: Revenue Share, by Business Segment, 2021
Figure 28: Siemens Healthineers: Revenue Share, by Region, 2021
Figure 29: Thermo Fisher Scientific: Annual Revenue, 2019-2021
Figure 30: Thermo Fisher Scientific: Revenue Share, by Business Segment, 2021
Figure 31: Thermo Fisher Scientific: Sales Share, by Region, 2021
Figure 32: Thermo Fisher Scientific: Products Share, 2021
Samples
LOADING...
Executive Summary
Growth factors include rising incidence of chronic disease such as cancer, diabetes, autoimmune diseases, cardiovascular diseases, and infectious diseases such as influenza, HIV and tuberculosis. Other factors include increasing adoption and use of immunoassays in oncology due to test specificity, and a growing trend in application of immunoassay products in drug discovery and development, basic research, and environmental testing such as detecting food and water contamination.
In 2020, the COVID-19 pandemic led to the temporary cessation of routine diagnostic procedures, including immunoassay testing, in hospitals, clinics and diagnostic centers worldwide. However, these procedures largely resumed in the second half of 2021, which is driving growth in the global market for immunoassays.
Companies Mentioned
- Abbott Laboratories
- Abcam Plc
- Beckman Coulter (Danaher Corp.)
- Biomerieux S.A.
- Bio-Rad Laboratories Inc.
- Diasorin
- Merck Inc.
- Mindray
- Orasure Technologies
- Perkin Elmer
- Quidel Corp.
- Randox Laboratories Ltd.
- Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
- Sd Biosensor
- Siemens Healthineers
- Thermo Fisher Scientific Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 127 |
| Published | February 2023 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value ( USD | $ 30.6 Billion |
| Forecasted Market Value ( USD | $ 39.8 Billion |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
